Back to search

Article

Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spots

2024-01-30

Abstract excerpt

<h4>ABSTRACT</h4> The level of neutralizing antibodies required to confer protection against COVID-19 breakthrough infections (BIs) is unclear, and the ability to know the immune status of individuals against the rapidly changing endemic variants is limited. We assessed longitudinal serum anti-RBD antibody levels and neutralizing activities (NTs) against Omicron BA.5 and XBB.1.5 in healthcare workers following the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad6e0fa6-b75b-5beb-bcf0-5278f9adc459
DOI
10.1101/2024.01.30.24301988
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spotsDOI 10.1101/2024.01.30.24301988
Neutralizing antibody levels and epidemiological information of patients with breakthrough COVID-19 infection in Toyama, JapanSemantic proximity
XBB .1.5 neutralizing antibodies upon bivalent COVID ‐19 vaccination are similar to XBB but lower than BQ .1.1Semantic proximity
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity
Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic StudiesSemantic proximity
Humoral and cellular response three months following bivalent booster administrationSemantic proximity
Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccineSemantic proximity
Finger stick blood test to assess post vaccination SARS-CoV-2 neutralizing antibody response against variantsSemantic proximity
Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic StudiesSemantic proximity
COVID-19 breakthrough infections and pre-infection neutralizing antibodySemantic proximity
Virus neutralizing antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccineSemantic proximity
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent BoosterSemantic proximity
The response to BTN62b2 booster doses demonstrates that serum antibodies do not predict the establishment of immune B-cell memory in common variable immune deficienciesSemantic proximity
Select a neighboring publication to make it the new centre.